Toxicity	toxicity	O	DISEASE	OTHERS	I
in	in	O	O	O	O
rhesus	rhesus	O	O	O	O
monkeys	monkeys	O	O	O	O
following	following	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
8-aminoquinoline	8-aminoquinoline	CHEMICALS	O	OTHERS	I
8-[(4-amino-l-methylbutyl)amino]-	8-[(4-amino-l-methylbutyl)amino]-	O	O	O	O
5-(l-hexyloxy)-6-methoxy-4-methylquinoline	5-(l-hexyloxy)-6-methoxy-4-methylquinoline	O	O	O	O
(WR242511).INTRODUCTION	(wr242511).introduction	O	O	O	O
:	:	O	O	O	O
Many	many	O	O	O	O
substances	substances	O	O	O	O
that	that	O	O	O	O
form	form	O	O	O	O
methemoglobin	methemoglobin	O	O	O	O
(	(	O	O	O	O
MHb	mhb	O	O	O	O
)	)	O	O	O	O
effectively	effectively	O	O	O	O
counter	counter	O	O	O	O
cyanide	cyanide	O	O	O	O
(	(	O	O	O	O
CN	cn	O	O	O	O
)	)	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Although	although	O	O	O	O
MHb	mhb	O	O	O	O
formers	formers	O	O	O	O
are	are	O	O	O	O
generally	generally	O	O	O	O
applied	applied	O	O	O	O
as	as	O	O	O	O
treatments	treatments	O	O	O	O
for	for	O	O	O	O
CN	cn	O	O	O	O
poisoning	poisoning	O	DISEASE	OTHERS	I
,	,	O	O	O	O
it	it	O	O	O	O
has	has	O	O	O	O
been	been	O	O	O	O
proposed	proposed	O	O	O	O
that	that	O	O	O	O
a	a	O	O	O	O
stable	stable	O	O	O	O
,	,	O	O	O	O
long-acting	long-acting	O	O	O	O
MHb	mhb	O	O	O	O
former	former	O	O	O	O
could	could	O	O	O	O
serve	serve	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
CN	cn	O	O	O	O
pretreatment	pretreatment	O	O	O	O
.	.	O	O	O	O

Using	using	O	O	O	O
this	this	O	O	O	O
rationale	rationale	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
8-aminoquinoline	8-aminoquinoline	CHEMICALS	O	OTHERS	I
WR242511	wr242511	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
potent	potent	O	O	O	O
long-lasting	long-lasting	O	O	O	O
MHb	mhb	O	O	O	O
former	former	O	O	O	O
in	in	O	O	O	O
rodents	rodents	O	O	O	O
and	and	O	O	O	O
beagle	beagle	O	O	O	O
dogs	dogs	O	O	O	O
,	,	O	O	O	O
was	was	O	O	O	O
studied	studied	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
rhesus	rhesus	O	O	O	O
monkey	monkey	O	O	O	O
for	for	O	O	O	O
advanced	advanced	O	O	O	O
development	development	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
potential	potential	O	O	O	O
CN	cn	O	O	O	O
pretreatment	pretreatment	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
In	in	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
WR242511	wr242511	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
administered	administered	O	O	O	O
intravenously	intravenously	O	O	O	O
(	(	O	O	O	O
IV	iv	O	O	O	O
)	)	O	O	O	O
in	in	O	O	O	O
2	2	O	O	O	O
female	female	O	O	O	O
and	and	O	O	O	O
4	4	O	O	O	O
male	male	O	O	O	O
rhesus	rhesus	O	O	O	O
monkeys	monkeys	O	O	O	O
in	in	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
3.5	3.5	O	O	O	O
and/or	and/or	O	O	O	O
7.0	7.0	O	O	O	O
mg/kg	mg/kg	O	O	O	O
;	;	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
male	male	O	O	O	O
also	also	O	O	O	O
received	received	O	O	O	O
WR242511	wr242511	CHEMICALS	O	OTHERS	I
orally	orally	O	O	O	O
(	(	O	O	O	O
PO	po	O	O	O	O
)	)	O	O	O	O
at	at	O	O	O	O
7.0	7.0	O	O	O	O
mg/kg	mg/kg	O	O	O	O
.	.	O	O	O	O

Health	health	O	O	O	O
status	status	O	O	O	O
and	and	O	O	O	O
MHb	mhb	O	O	O	O
levels	levels	O	O	O	O
were	were	O	O	O	O
monitored	monitored	O	O	O	O
following	following	O	O	O	O
exposure	exposure	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
selected	selected	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
WR242511	wr242511	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
produced	produced	O	O	O	O
significant	significant	O	O	O	O
methemoglobinemia	methemoglobinemia	O	O	OTHERS	I
in	in	O	O	O	O
beagle	beagle	O	O	O	O
dogs	dogs	O	O	O	O
in	in	O	O	O	O
earlier	earlier	O	O	O	O
studies	studies	O	O	O	O
conducted	conducted	O	O	O	O
elsewhere	elsewhere	O	O	O	O
,	,	O	O	O	O
produced	produced	O	O	O	O
very	very	O	O	O	O
little	little	O	O	O	O
MHb	mhb	O	O	O	O
(	(	O	O	O	O
mean	mean	O	O	O	O
<	<	O	O	O	O
2.0	2.0	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
rhesus	rhesus	O	O	O	O
monkey	monkey	O	O	O	O
.	.	O	O	O	O

Furthermore	furthermore	O	O	O	O
,	,	O	O	O	O
transient	transient	O	O	O	O
hemoglobinuria	hemoglobinuria	O	O	OTHERS	I
was	was	O	O	O	O
noted	noted	O	O	O	O
approximately	approximately	O	O	O	O
60	60	O	O	O	O
minutes	minutes	O	O	O	O
postinjection	postinjection	O	O	O	O
of	of	O	O	O	O
WR242511	wr242511	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
3.5	3.5	O	O	O	O
or	or	O	O	O	O
7.0	7.0	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
2	2	O	O	O	O
lethalities	lethalities	O	O	O	O
occurred	occurred	O	O	O	O
(	(	O	O	O	O
one	one	O	O	O	O
IV	iv	O	O	O	O
and	and	O	O	O	O
one	one	O	O	O	O
PO	po	O	O	O	O
)	)	O	O	O	O
following	following	O	O	O	O
the	the	O	O	O	O
7.0	7.0	O	O	O	O
mg/kg	mg/kg	O	O	O	O
dose	dose	O	O	O	O
.	.	O	O	O	O

Myoglobinuria	myoglobinuria	O	O	OTHERS	I
was	was	O	O	O	O
also	also	O	O	O	O
observed	observed	O	O	O	O
following	following	O	O	O	O
the	the	O	O	O	O
7.0	7.0	O	O	O	O
mg/kg	mg/kg	O	O	O	O
dose	dose	O	O	O	O
.	.	O	O	O	O

Histopathology	histopathology	O	O	O	O
analyses	analyses	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
2	2	O	O	O	O
animals	animals	O	O	O	O
that	that	O	O	O	O
died	died	O	O	O	O
revealed	revealed	O	O	O	O
liver	liver	O	O	O	O
and	and	O	O	O	O
kidney	kidney	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
,	,	O	O	O	O
with	with	O	O	O	O
greater	greater	O	O	O	O
severity	severity	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
orally-treated	orally-treated	O	O	O	O
animal	animal	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
These	these	O	O	O	O
data	data	O	O	O	O
demonstrate	demonstrate	O	O	O	O
direct	direct	O	O	O	O
and/or	and/or	O	O	O	O
indirect	indirect	O	O	O	O
drug-induced	drug-induced	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
concluded	concluded	O	O	O	O
that	that	O	O	O	O
WR242511	wr242511	CHEMICALS	O	OTHERS	I
should	should	O	O	O	O
not	not	O	O	O	O
be	be	O	O	O	O
pursued	pursued	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
pretreatment	pretreatment	O	O	O	O
for	for	O	O	O	O
CN	cn	O	O	O	O
poisoning	poisoning	O	DISEASE	OTHERS	I
unless	unless	O	O	O	O
the	the	O	O	O	O
anti-CN	anti-cn	O	O	O	O
characteristics	characteristics	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
compound	compound	O	O	O	O
can	can	O	O	O	O
be	be	O	O	O	O
successfully	successfully	O	O	O	O
dissociated	dissociated	O	O	O	O
from	from	O	O	O	O
those	those	O	O	O	O
producing	producing	O	O	O	O
undesirable	undesirable	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

